Health Investor Circle Breakfast: Investing in Opioid Crisis Solutions

Rates of Opioid Use Disorder (OUD) are at an all-time high in the U.S. and public funding is not expected to cover even a fraction of what is needed. Private capital is urgently needed, and for-profit companies are creating data-driven diagnostics and therapeutics to identify and treat OUD patients in more targeted ways. Doug Leslie, PhD, Director of the Center for Applied Studies in Health Economics, Penn State University, Keri Donaldson, CEO & Medical Director, Prescient Medicine and Joy Sun, Co-Founder & COO, Groups, will shed light on which technologies and companies are gaining the most traction in OUD diagnosis and treatment.

This event is by invite only for private investors, wealth managers and family offices with decision-making authority over financial resources.

For more information, please contact Mae Hsieh.